Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
Sponsor: Sichuan Jishengtang Pharmaceutical Co., Ltd.
Summary
This is a randomized double-blind placebo-controlled phase 3 clinical trial to further validate the effectiveness and safety of Shugan Jieyu Capsules in treating generalized anxiety disorder.
Official title: A Multi-center, Randomized, Double-Blind Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
495
Start Date
2023-04-17
Completion Date
2025-06-01
Last Updated
2024-12-18
Healthy Volunteers
No
Conditions
Interventions
Shugan Jieyu Capsules
Oral, 4 Capsules, BID
Shugan Jieyu Capsules Placebo
Drug: Shugan Jieyu Capsules Placebo, Oral,4 capsules,BID Drug: Placebo, Oral, 1 capsule, BID
Locations (1)
Beijing Anding Hospital Affiliated to Capital Medical University
Beijing, China